The Quiet Revolution: How Small Biotechs are Outpacing Big Pharma
In 2024, biotech firms were responsible for nearly two-thirds of new drug approvals by the U.S. FDA. Smaller biotechs are increasingly choosing market independence, challenging traditional Big Pharma dominance. Advancements…